Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Fuster

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2022
An intermediate-effect size variant in <i>UMOD</i> confers risk for chronic kidney diseaseEric Olinger, Céline Schaeffer, Kendrah Kidd, et al.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2025
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE TrialAndreas Christe, Elias Primetis, Grazia M Cereghetti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2025
Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working GroupPaul Geertsema, Ron T Gansevoort, Mustafa Arici, et al.
Kidney International|May 26, 2020
Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1Eric Olinger, Patrick Hofmann, Kendrah Kidd, et al.
The New England Journal of Medicine|March 31, 2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1Sander F Garrelfs, Yaacov Frishberg, Sally A Hulton, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2022
An intermediate-effect size variant in <i>UMOD</i> confers risk for chronic kidney diseaseEric Olinger, Céline Schaeffer, Kendrah Kidd, et al.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2025
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE TrialAndreas Christe, Elias Primetis, Grazia M Cereghetti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2025
Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working GroupPaul Geertsema, Ron T Gansevoort, Mustafa Arici, et al.
Kidney International|May 26, 2020
Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1Eric Olinger, Patrick Hofmann, Kendrah Kidd, et al.
The New England Journal of Medicine|March 31, 2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1Sander F Garrelfs, Yaacov Frishberg, Sally A Hulton, et al.
Pageof 9